Loading…
LifeMD, Inc. is projected to rise to $3.95 by 2027, a +13% move from its current price of $3.50. LFMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $3.38 | $3.50 | $3.62 | -0.02% |
| Aug 5 | $3.33 | $3.50 | $3.68 | -0.04% |
| Aug 6 | $3.29 | $3.50 | $3.72 | -0.06% |
| Aug 7 | $3.26 | $3.50 | $3.75 | -0.08% |
| Aug 8 | $3.23 | $3.50 | $3.78 | -0.10% |
| Aug 9 | $3.21 | $3.50 | $3.81 | -0.12% |
| Aug 10 | $3.19 | $3.50 | $3.83 | -0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.19 | $3.50 | $3.83 | -0.14% |
| Week 2 | $3.06 | $3.49 | $3.98 | -0.28% |
| Week 3 | $2.97 | $3.49 | $4.09 | -0.42% |
| Week 4 | $2.89 | $3.48 | $4.19 | -0.56% |
| Week 5 | $2.82 | $3.48 | $4.28 | -0.70% |
| Week 6 | $2.77 | $3.47 | $4.36 | -0.84% |
| Week 7 | $2.71 | $3.47 | $4.43 | -0.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeMD, Inc. is a healthcare company that operates as a direct-to-patient telehealth provider, offering patients access to virtual medical care and pharmacy services in the United States. Its telehealth platform comprises Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions such as erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD, which provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.
LifeMD PC is a virtual primary care and telehealth service that serves as a provider for primary care, urgent care, and chronic care needs, offering virtual medical care including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. The company also offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc.
and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
LifeMD, Inc. (LFMD) is currently priced at $3.71 with a market cap of $179.42M and ranks 3658. The stock sits in a neutral near-term posture with a 30-day technical picture showing mixed momentum and defined support and resistance levels. The annualized volatility stands at 70%, underscoring a high-variance environment around the current price.
In the near term, forecast figures for 2026 show a neutral stance with an average price of $3.71 and a price range between $2.64 and $4.73. Over the longer horizon, the forecast turns bullish with rising averages and steeply growing ROIs through 2050, suggesting meaningful upside potential despite near-term ambiguity.
A major floor 26.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 40.3% above — a clean break opens room to run.
A major ceiling 53.7% above — clearing it would confirm fresh momentum.
Key LFMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.70 | Sell | $3.67 | Sell |
| MA 10 | $3.84 | Sell | $3.84 | Sell |
| MA 20 | $4.23 | Sell | $4.07 | Sell |
| MA 50 | $4.43 | Sell | $4.28 | Sell |
| MA 100 | $4.31 | Sell | $4.31 | Sell |
| MA 200 | $4.15 | Sell | $4.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.77 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -118.04 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -22.74 | Sell |
| Bollinger %B (20,2) | 0.10 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.57 | Sell |
| Awesome (5,34) | -0.66 | Sell |
| Ultimate (7,14,28) | 23.86 | Buy |
| Momentum (10) | -0.65 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 3.57 | Sell |
| ADX (14) | 19.30 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is Neutral, with RSI(14) at 30 and price action hovering around key moving averages. The stock trades near the SMA50 of $4.50 and the SMA200 of $4.22, providing near-term reference levels for support and resistance.
Current support is identified at $3.71, while resistance is noted at $4.91. The 30-day price range runs from a low of $2.91 to a high of $4.74, indicating a relatively wide short-term band and suggesting caution around breakouts above or below this span.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.64 | $3.50 | $4.47 | 0% | Neutral | |
| $3.07 | $3.95 | $5.43 | +13% | Neutral | |
| $4.05 | $5.41 | $7.77 | +54% | Bullish | |
| $3.99 | $5.50 | $8.19 | +57% | Bullish | |
| $3.86 | $5.47 | $8.40 | +56% | Bullish | |
| $4.27 | $6.21 | $9.78 | +77% | Bullish | |
| $3.88 | $5.77 | $9.31 | +65% | Bullish | |
| $3.97 | $6.04 | $9.94 | +73% | Bullish | |
| $4.83 | $7.50 | $12.59 | +114% | Bullish | |
| $5.34 | $8.47 | $14.46 | +142% | Bullish | |
| $5.88 | $10.26 | $18.86 | +193% | Bullish | |
| $10.51 | $21.72 | $44.37 | +521% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.64 | $3.50 | $4.20 | +0.00% |
| September 2026 | $2.80 | $3.34 | $4.12 | -4.45% |
| October 2026 | $2.86 | $3.44 | $4.29 | +2.75% |
| November 2026 | $2.94 | $3.56 | $4.50 | +3.71% |
| December 2026 | $2.88 | $3.51 | $4.47 | -1.58% |
Click any year to see its month-by-month LFMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect LFMD to range from $2.64 to $4.47 through 2026. The $3.50 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The LFMD price prediction for 2027 points to an average of $3.95 (low $3.07, high $5.43) — a potential gain of +13% on today's $3.50. A consolidation phase looks the most probable path here.
In 2028, LFMD is projected to trade between $4.05 and $7.77, averaging $5.41 — a potential gain of +54% from today's $3.50. That is up +37% on the projected 2027 average. Momentum favours further upside here.
LifeMD, Inc.'s 2029 outlook centres on $5.50, within a $3.99 to $8.19 range. That is up +2% on the projected 2028 average. That marks a +57% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, LFMD could reach as high as $8.40, with a base case around $5.47 and support toward $3.86 — roughly +56% from $3.50. Momentum favours further upside here.
Expect LFMD to range from $4.27 to $9.78 through 2031. The $6.21 average target implies a +77% move from current prices. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The LFMD price prediction for 2032 points to an average of $5.77 (low $3.88, high $9.31) — a potential gain of +65% on today's $3.50. Momentum favours further upside here.
In 2033, LFMD is projected to trade between $3.97 and $9.94, averaging $6.04 — a potential gain of +73% from today's $3.50. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
LifeMD, Inc.'s 2034 outlook centres on $7.50, within a $4.83 to $12.59 range. That is up +24% on the projected 2033 average. That marks a +114% change versus current levels. Momentum favours further upside here.
By 2035, LFMD could reach as high as $14.46, with a base case around $8.47 and support toward $5.34 — roughly +142% from $3.50. Buyers look set to stay in control over this stretch.
Expect LFMD to range from $5.88 to $18.86 through 2040. The $10.26 average target implies a +193% move from current prices. That is up +21% on the projected 2035 average. Momentum favours further upside here.
The LFMD price prediction for 2050 points to an average of $21.72 (low $10.51, high $44.37) — a potential gain of +521% on today's $3.50. Buyers look set to stay in control over this stretch.
Investing $1,000 in LFMD today (≈ 285.714286 LFMD) could be worth
$6,205.84
+$5,205.84 (+521%) by 2050 · US Dollar
Based on the average projected LFMD price of $21.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFMDwould be worth at today's price.
$1,000 invested in LFMD on Jul 31, 2025 (≈ 96.061481 LFMD) would be worth
$336.22
-$663.78 (-66.4%) today · 0.34× · US Dollar
Based on a LFMD entry price of $10.41 vs. today's $3.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.71 | $943.4 | -5.7% |
| 1 month ago | $4.54 | $770.93 | -22.9% |
| 3 months ago | $5 | $700 | -30.0% |
| 6 months ago | $3.28 | $1,067.07 | +6.7% |
| 1 year ago | $10.41 | $336.22 | -66.4% |
| All time (5.0y) ago | $9.72 | $360.08 | -64.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFMD forecast.
Our base-case forecast reaches $7.00 around 2034.
Implied market cap at $7.00: $338.54M
The multi-year forecast paints a bullish outlook after a neutral start in 2026. The average price rises from $3.71 in 2026 to higher levels across the horizon, with 2030 posting an average of $5.81 and a max of $9.05 for a 56.7% ROI. By 2040, the average is projected at $10.51 with an ROI of 183.3%, and by 2050 the average reaches $22.32 with an ROI of 501.7%.
The forecast also highlights substantial upside in the later years, including a 2031 average of $6.53 and a max of $10.45 (76.1% ROI) and a 2050 max of $46.72. These projections are paired with a bullish sentiment from 2028 onward, indicating the potential for meaningful appreciation if the assumptions hold. However, the predictions remain estimates and are not guarantees; the asset can experience significant volatility and drawdowns in the interim, consistent with the stated 70% annualized volatility.
Tap a question to reveal the answer.
In 2030 the forecast shows a min of $4.05, an average of $5.81, and a max of $9.05, with an ROI of 56.7%. The sentiment is BULLISH.
The near-term forecast for 2026 shows an average price of $3.71 with an ROI of 0% and NEUTRAL sentiment. From 2027 onward, the outlook turns increasingly bullish, with ROIs up to 501.7% by 2050, though these are estimates and not guarantees.
Yes. In 2031 the max price is $10.45 and the average is $6.53, indicating the potential to exceed $10 under the max scenario within the forecast.
The current price is $3.71. The 30-day range is from $2.91 to $4.74, with a support at $3.71 and resistance at $4.91.
The 30-day outlook shows a range of $2.91 to $4.74, with RSI(14) at 30, SMA50 at $4.50, SMA200 at $4.22, and a defined support of $3.71 and resistance of $4.91; overall sentiment is NEUTRAL.
LifeMD, Inc. Community Discussion
0Share your LifeMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.